MiR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study

Atherosclerosis

Volumn 219, Issue 1, 2011, Pages 211-217

  Raitoharju, Emma ^a   Lyytikäinen, Leo Pekka ^a   Levula, Mari ^a   Oksala, Niku ^a   Mennander, Ari ^a   Tarkka, Matti ^a   Klopp, Norman ^b   Illig, Thomas ^b   Kähönen, Mika ^a   Karhunen, Pekka J ^a   Laaksonen, Reijo ^a   Lehtimäki, Terho ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Atherosclerosis; Expression; MiRNA; Plaque; Target

Indexed keywords

MICRORNA; MICRORNA 21;

AGED; AORTA; ARTERY RUPTURE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CLINICAL ARTICLE; ENDARTERECTOMY; FEMALE; FEMORAL ARTERY; GENE EXPRESSION; GENOME; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MAMMARY ARTERIES; MICRORNAS; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; UP-REGULATION;

EID: 80054973471     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.07.020     Document Type: Article

References (30)

1. Borchert G.M., Lanier W., Davidson B.L. RNA polymerase III transcribes human microRNAs. Nature Structural and Molecular Biology 2006, 13:1097-1101.
2. Silvestri P., Di Russo C., Rigattieri S., et al. MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets. Recent Patents on Cardiovascular Drug Discovery 2009, 4:109-118.
3. Ross R. Atherosclerosis -- an inflammatory disease. The New England Journal of Medicine 1999, 340:115-126.
4. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clinical Chemistry 2008, 54:24-38.
5. Weber C., Schober A., Zernecke A. MicroRNAs in arterial remodelling, inflammation and atherosclerosis. Current Drug Targets 2010, 11:950-956.
6. Urbich C., Kuehbacher A., Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovascular Research 2008, 79:581-588.
7. Ji R., Cheng Y., Yue J., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circulation Research 2007, 100:1579-1588.
8. Li T., Cao H., Zhuang J., et al. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clinica Chimica Acta; International Journal of Clinical Chemistry 2010, 412:66-70.
9. Subramanian A., Tamayo P., Mootha V.K., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:15545-15550.
10. Weber M., Baker M.B., Moore J.P., Searles C.D. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochemical and Biophysical Research Communications 2010, 393:643-648.
11. Gabriely G., Wurdinger T., Kesari S., et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Molecular and Cellular Biology 2008, 28:5369-5380.
12. Schmeier S., MacPherson C.R., Essack M., et al. Deciphering the transcriptional circuitry of microRNA genes expressed during human monocytic differentiation. BMC Genomics 2009, 10:595.
13. Hashimi S.T., Fulcher J.A., Chang M.H., et al. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 2009, 114:404-414.
14. Surks H.K., Riddick N., Ohtani K. M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells. The Journal of Biological Chemistry 2005, 280:42543-42551.
15. Caolo V., Schulten H.M., Zhuang Z.W., et al. Soluble Jagged-1 inhibits neointima formation by attenuating notch-Herp2 signaling. Arteriosclerosis, Thrombosis and Vascular Biology 2011, 31:1059-1065.
16. Cardellini M., Menghini R., Martelli E., et al. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 2009, 58:2396-2401.
17. He L., He X., Lim L.P., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
18. Ichimura A., Ruike Y., Terasawa K., Shimizu K., Tsujimoto G. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Molecular Pharmacology 2010, 77:1016-1024.
19. Brinck U., Mirzaie M., Korabiowska M., Meyer T. Expression rate of vinculin isoforms in human aortocoronary saphenous vein grafts. International Journal of Cardiology 1997, 59:125-132.
20. Ma L., Yang J., Runesha H.B., et al. Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data. BMC Medical Genetics 2010, 11:55.
21. Takahashi Y., Satoh M., Minami Y., et al. Expression of microRNA-146a/b is associated with Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statin on microRNA-146a/b and Toll-like receptor 4 levels. Clinical Science (London) 2010, 119:395-405.
22. Li L., Chen X.P., Li Y.J. MicroRNA-146a and human disease. Scandinavian Journal of Immunology 2010, 71:227-231.
23. Chen T., Huang Z., Wang L., et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovascular Research 2009, 83:131-139.
24. Bhaumik D., Scott G.K., Schokrpur S., et al. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging 2009, 1:402-411.
25. Li Y., Vandenboom T.G., Wang Z., et al. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Research 2010, 70:1486-1495.
26. Kjolby M., Andersen O.M., Breiderhoff T., et al. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metabolism 2010, 12:213-223.
27. Ivan M., Harris A.L., Martelli F., Kulshreshtha R. Hypoxia response and microRNAs: no longer two separate worlds. Journal of Cellular and Molecular Medicine 2008, 12:1426-1431.
28. Jeyaseelan K., Lim K.Y., Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke; A Journal of Cerebral Circulation 2008, 39:959-966.
29. Beilke S., Oswald F., Genze F., et al. The zinc-finger protein KCMF1 is overexpressed during pancreatic cancer development and downregulation of KCMF1 inhibits pancreatic cancer development in mice. Oncogene 2010, 29:4058-4067.
30. Mercer J., Mahmoudi M., Bennett M. DNA damage, p53, apoptosis and vascular disease. Mutation Research 2007, 621:75-86.